HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-08Clinical Trial Update: Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX [Phase 2]
Phase 2 trial comparing adherence to HIV therapy between oral medication and extended-release naltrexone in individuals with heroin addictio…
-
FDA approval · 2018-11-06FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
The FDA approved a supplemental application for etravirine submitted by Patriot Pharmaceuticals. The action represents approval of a supplem…
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: A Smoking Cessation Trial in HIV-infected Patients in South Africa [NA]
A completed smoking cessation clinical trial in HIV-infected patients in South Africa; results posted in 2018.
-
FDA approval · 2018-11-02FDA Approved: STRIBILD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for STRIBILD from Gilead, updating the drug's labeling to reflect the supplemental submission.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women [Phase 3]
Phase 3 trial update evaluating safety and efficacy of switching virologically suppressed women to a fixed-dose combination of B/F/TAF from …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects [Phase 3]
A Phase 3 trial of CCR5 antagonist GW873140 in treatment-experienced HIV patients was terminated; results were posted in 2018.
-
FDA approval · 2018-11-02FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) from Gilead Science…
-
FDA approval · 2018-10-31FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for COMPLERA (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate).
-
FDA approval · 2018-10-31FDA Approved: ODEFSEY — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for ODEFSEY (emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide) from Gilead Scienc…
-
FDA approval · 2018-10-30FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for TYBOST (cobicistat) submitted by Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: Microbiota Restoration Therapy in HIV With Repeated Low-Dose Interventions [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating repeated low-dose microbiota restoration therapy in HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults
A completed clinical trial comparing virologic and immunologic responses to raltegravir and dolutegravir in the gastrointestinal tract of HI…
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: Improving the Health of South African Women With Traumatic Stress in HIV Care (C0147) [NA]
A completed Duke University–sponsored clinical trial (NCT02223390) evaluating interventions to improve health outcomes for South African wom…
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: HIV Vaccine Trial in Thai Adults [Phase 3]
Phase 3 HIV vaccine trial in Thai adults completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection [Phase 2]
Phase 2 trial evaluating the safety and therapeutic efficacy of the VRC01 antibody in patients who started antiretroviral therapy during ear…
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir [Phase 4]
Phase 4 trial evaluating bone mineral density changes in HIV-positive females with osteopenia who switch to raltegravir; study terminated.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis [Phase 3]
Phase 3 trial evaluating E/C/F/TAF fixed-dose combination in HIV-1 infected adults on chronic hemodialysis completed with results posted in …
-
CLINICAL_TRIALS research · 2018-10-16Clinical Trial Update: Reducing HIV Risk Among Adolescents: Evaluating Project HEART [NA]
Clinical trial update evaluating Project HEART aimed at reducing HIV risk among adolescents; study status completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: Cognitive Training With and Without tDCS to Improve Cognition in HIV [NA]
Clinical trial update for cognitive training with or without transcranial direct current stimulation (tDCS) in HIV patients with mild neuroc…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission [Phase 3]
Phase 3 clinical trial update on HSV-2 suppression to reduce HIV transmission in individuals with HIV infection and genital herpes; study co…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: The HJ MILE HIV Prevention Intervention for Post-incarcerated Men [Phase 3]
Phase 3 clinical trial update for the HJ MILE HIV prevention intervention targeting post-incarcerated men; study completed.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: mVIP (Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV) [NA]
Clinical trial completed evaluating mVIP, a mobile health technology to support symptom management in underserved persons living with HIV; r…
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: Doxycycline for COPD in HIV-Infected Patients [NA]
A completed clinical trial assessing doxycycline for COPD in HIV-infected patients; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment [Phase 3]
Phase 3 trial update evaluating the efficacy, safety, and tolerability of LDV/SOF treatment for HIV/HCV co-infected participants who switch …
-
CLINICAL_TRIALS research · 2018-10-05Clinical Trial Update: The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients [Phase 4]
Phase 4 clinical trial investigating the effects of statin therapy on coronary flow reserve and inflammatory markers in HIV-positive patient…